Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
about
Myeloid-derived suppressor cells as therapeutic target in hematological malignanciesIFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.Transcriptional regulation of myeloid-derived suppressor cells.A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4.Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.STAT of the union: dynamics of distinct tumor-associated macrophage subsets governed by STAT1.Unsuspected allies: chemotherapy teams up with immunity to fight cancer.BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity.TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
P2860
Q27010234-A8049B41-1193-4DA3-BF90-C7149558B2A8Q34076238-837A26C3-DB51-43CE-AFE8-CA05A6B3C705Q34365909-A79AE8F7-E4D5-411A-9FAD-9D0971E72BB2Q35506459-BEBFD3C5-688C-44CC-AF78-8C107B8FB651Q36275124-84D8C99C-6F3B-4F10-B70F-D3972022CD33Q36322351-A73D59EE-4EE8-4211-B5BD-81C1EECBC7EFQ36356265-60652C67-F30A-4316-998F-2A3E44B3EE8FQ36467210-1EED5FE1-DF32-48A5-AC72-01B816280211Q37541609-F70A2C38-CB45-4B7F-B0B5-54B9545ECC9CQ38398117-951A5E22-5556-4768-B02F-15DB7AE30736Q38771038-8EACD5CB-9F8F-4BE1-A83E-BB62F00D544BQ38929374-D0402D3D-BE19-4907-AEF3-20C868D902A9Q38939956-A2B156A6-085C-420A-865E-EFCD5C78EEAAQ39168056-D0673388-0C35-41A7-9E9C-0E069259F00FQ39333424-AECB9EB5-A24E-471B-83C1-0AD9675B2725Q42731020-24C979F1-983A-4384-BAC4-F84391FBA87EQ49977478-64D4A212-E593-496E-BE24-60778CF6CF2AQ57817490-D7C08196-BB2D-4879-91B7-2C17990CE599
P2860
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@en
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@nl
type
label
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@en
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@nl
prefLabel
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@en
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@nl
P2093
P2860
P356
P1476
Tumor-induced myeloid-derived ...... CD8+ T-cell activation events.
@en
P2093
Ariane Luyckx
Camille Mommer
Conny Gysemans
Damya Laoui
Elio Schouppe
Jo A Van Ginderachter
Kiavash Movahedi
Patrick De Baetselier
Yannick Morias
P2860
P304
P356
10.1002/EJI.201343349
P407
P577
2013-08-25T00:00:00Z